Hinge Health Inc. (NYSE:HNGE - Get Free Report)'s share price rose 10.7% during trading on Tuesday . The stock traded as high as $48.85 and last traded at $48.37. Approximately 904,399 shares traded hands during trading, an increase of 5% from the average daily volume of 862,172 shares. The stock had previously closed at $43.69.
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on HNGE. Wall Street Zen upgraded shares of Hinge Health to a "hold" rating in a research report on Monday, June 2nd. Morgan Stanley started coverage on Hinge Health in a research report on Monday, June 16th. They set an "overweight" rating and a $46.00 price target on the stock. Stifel Nicolaus assumed coverage on Hinge Health in a research report on Monday, June 16th. They issued a "buy" rating and a $48.00 price objective for the company. Needham & Company LLC started coverage on Hinge Health in a research report on Monday, June 16th. They set a "buy" rating and a $47.00 target price on the stock. Finally, Truist Financial began coverage on shares of Hinge Health in a research note on Monday, June 16th. They issued a "buy" rating and a $48.00 price target on the stock. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $46.00.
Read Our Latest Stock Analysis on HNGE
Hinge Health Trading Up 6.2%
About Hinge Health
(
Get Free Report)
Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
